Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers

BACKGROUND: The impact of age on the efficacy and safety of immunotherapy remains controversial. The previous studies simply classified patients into younger and older groups, which might not reflect the real impact of young age on immunotherapy efficacy. The current study aimed to explore the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yingnan, Zhang, Shasha, Zhang, Fengbin, Wang, Lei, Wu, Chensi, Zhang, Xiaoyun, Zhang, Ruixing, Guo, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189879/
https://www.ncbi.nlm.nih.gov/pubmed/37207161
http://dx.doi.org/10.3389/fonc.2023.1155019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189879/
https://www.ncbi.nlm.nih.gov/pubmed/37207161
http://dx.doi.org/10.3389/fonc.2023.1155019

Ejemplares similares